癌治療藥及製藥企業的最新動向：第6版

Abstract

The new 6th edition of this respected management report is the essential reference work for everyone in the field. The report covers 121 companies - from the largest blue-chip multinational to smaller specialist organisations - and all phases of development from research to launched products.

Detailed analysis of the structure, performance and research of leading cancer drug development companies.

By 2012, the global cancer market is expected to generate revenues in excess of US$65 billion due to growth in the sales of existing products and the launch of nearly 60 new products, which will account for around 30% of total drug launches. These will offset the decline in sales of cytotoxics and antihormonals, which face generic competition and the uptake of newer products in preference to these older agents.

The cancer treatment market is set to change radically as newer targeted therapies replace broader spectrum treatments. They are generally better tolerated, less toxic and provide better patient outcomes. A trend also to be noted is the rise of combination therapies and earlier drug intervention, often at the surgical stage. Against these positive trends is a growing concern about the rising cost of cancer drugs. With several products now costing US$10,000+, the balance of meeting medical demands against the cost of treatment is an issue in all developed countries.

In the challenging cancer therapeutic market, which companies have the products, research and thinking that will shape the future market?

The new updated and expanded 6th edition of this highly respected management report, Who' s Developing What in New Cancer Drugs 2007? is the essential reference work for everyone in the field. The report covers 121 companies - from the largest blue-chip multinational to smaller specialist organisations - and all phases of development from research to launched products.

Competition for market voice, valuable licensing deals and funding is fierce in a sector characterised by novel research and the promise of significant clinical benefits and commercial return.

Cancer continues to dominate industry research and investment as the search for really effective therapies hots up. The commercial rewards for companies that make significant breakthroughs in the cure or control of key cancers such as breast, ovarian, lung and prostate are considerable.

The application of biotechnology to the identification and development of drug candidates has seen a variety of novel paths pursued by a range of development companies.

For analysts, investors and pharmaceutical company executives, being able to readily and easily assess these companies, the research they are pursuing, products being developed, collaborators and financial performance/funding is key to understanding this sector of the pharmaceutical market.

Table of Contents

Volume 1: A - F

ACCESS PHARMACEUTICALS INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

ACTIVE BIOTECH AB

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ADVENTRX PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

AETERNA ZENTARIS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ALCHEMIA LIMITED

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ALFACELL CORPORATION

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ALLOS THERAPEUTICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• DISCONTINUED PROJECT
• FINANCIALS

AMBRILIA BIOPHARMA INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

AMGEN INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

ANGIOGENE PHARMACEUTICALS LTD

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS

ANTICANCER INCORPORATED

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS

ANTIGENICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ANTISENSE PHARMA GMBH

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ANTISOMA PLC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
  • DISCONTINUED AGREEMENT
• R&D PROJECTS
• FINANCIALS

ARIAD PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ARIUS RESEARCH INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ARK THERAPEUTICS GROUP PLC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ARQULE INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ARRAY BIOPHARMA INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ASTRAZENECA PLC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
  • DISCONTINUED PROJECTS
• FINANCIALS

ATTENUON LLC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS

AVAX TECHNOLOGIES INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

BAYER AG

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
  • DISCONTINUED AGREEMENT
• PRODUCT PORTFOLIO
• R&D PROJECTS
  • DEPRIORITISED PROJECTS
  • DISCONTINUED PROJECT
• FINANCIALS

BIOGEN IDEC INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

BIOMIRA INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

BIONUMERIK PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

BIOVEX INC

• R&D PIPELINE TABLE
• OVERVIEW
• R&D PROJECTS
• FINANCIALS

BRISTOL-MYERS SQUIBB COMPANY

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

BTG INTERNATIONAL LIMITED

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

CALLISTO PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

CAN-FITE BIOPHARMA LTD

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

CEL-SCI CORPORATION

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

CELGENE CORPORATION

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

CELL GENESYS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

CELL THERAPEUTICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

CEPHALON INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

CLAVIS PHARMA A/S

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

COLEY PHARMACEUTICAL GROUP

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

CURAGEN CORPORATION

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
  • DISCONTINUED PROJECT
• FINANCIALS

CYCLACEL LIMITED

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• PRODUCT PORTFOLIO
• FINANCIALS

CYTOKINETICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

DAIICHI SANKYO COMPANY LIMITED

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
  • DISCONTINUED AGREEMENT
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

DENDREON CORPORATION

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ELI LILLY AND COMPANY

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

ENDOCYTE INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ENTREMED INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ENZON PHARMACEUTICALS INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

EPICEPT CORPORATION

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

EXELIXIS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

FAVRILLE INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

Volume 2: G - M

GAMIDA CELL LTD

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

GENENTECH INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

GENITOPE CORPORATION

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

GENMAB A/S

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• DISCONTINUED AGREEMENT
• R&D PROJECTS
• FINANCIALS

GENTA INCORPORATED

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

GENVEC INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

GENZYME ONCOLOGY

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

GERON CORPORATION

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

GLAXOSMITHKLINE PLC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

GPC BIOTECH AG

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

HANA BIOSCIENCES INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

HUMAN GENOME SCIENCES INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
  • INACTIVE PROJECTS
• FINANCIALS

IDERA PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

IDM PHARMA INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

IMCLONE SYSTEMS INCORPORATED

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

IMMUNOGEN INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

IMMUNOMEDICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

INTROGEN THERAPEUTICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ISIS PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

KERYX BIOPHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

KIRIN HOLDINGS COMPANY LIMITED

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

KOSAN BIOSCIENCES INCORPORATED

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• DISCONTINUED AGREEMENT
• R&D PROJECTS
• FINANCIALS

KYOWA HAKKO KOGYO CO LTD

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

LIGAND PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

LORUS THERAPEUTICS INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

MARSHALL EDWARDS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

MEDAREX INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

MEDIGENE AG

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

MERCK KGAA

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
  • DISCONTINUED AGREEMENT
• PRODUCT PORTFOLIO
• R&D PROJECTS
  • DISCONTINUED PROJECT
• FINANCIALS

METHYLGENE INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

MGI PHARMA INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

MICROMET INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

MILLENNIUM PHARMACEUTICALS INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

Volume 3: N - Y

NEOPHARM INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
  • DISCONTINED AGREEMENT
• R&D PROJECTS
• FINANCIALS

NORTHWEST BIOTHERAPEUTICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

NOVACEA INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

NOVARTIS INTERNATIONAL AG

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

ONCOGENEX TECHNOLOGIES INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ONCOLYTICS BIOTECH INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ONYVAX LIMITED

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

ONYX PHARMACEUTICALS INC

• AGREEMENTS TABLE
• PRODUCT TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

OSI PHARMACEUTICALS INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

OXFORD BIOMEDICA PLC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

OXIGENE INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

PANACEA PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

PEREGRINE PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

PFIZER INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

PHARMACYCLICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

PHARMAMAR SA

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS

PHOTOCURE ASA

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

PROGEN PHARMACEUTICALS LIMITED

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

PROGENICS PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
  • DISCONTINUED PROJECT
• FINANCIALS

PROTHERICS PLC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

QUEST PHARMATECH INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

F HOFFMANN-LA ROCHE LTD

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• DISCONTINUED AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

SANOFI-AVENTIS GROUP

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

SCHERING-PLOUGH CORPORATION

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

SEATTLE GENETICS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

SPECTRUM PHARMACEUTICALS INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

SUPERGEN INC

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

SYNTA PHARMACEUTICALS CORP

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

TEKMIRA PHARMACEUTICALS CORPORATION

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

TELIK INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

TOPOTARGET A/S

• AGREEMENTS TABLE
• PRODUCT PORTFOLIO TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• PRODUCT PORTFOLIO
• R&D PROJECTS
• FINANCIALS

TRANSGENE SA

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

VICAL INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

VION PHARMACEUTICALS INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

VIREXX MEDICAL CORP

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

VIVENTIA BIOTECH INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

WILEX AG

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS

YM BIOSCIENCES INC

• AGREEMENTS TABLE
• R&D PIPELINE TABLE
• OVERVIEW
• AGREEMENTS
• R&D PROJECTS
• FINANCIALS